Kathy Sharrard2022-12-15T12:03:13+09:30Carina Biotech submits an Investigational New Drug (IND) application to the US FDA for LGR5-Targeted CAR-T Cell Therapy CandidateKathy Sharrard2022-12-15T12:03:13+09:30December 15th, 2022|
Kathy Sharrard2022-08-15T14:53:37+09:30Carina Biotech raises $7.5 million at first close with Tenmile as the cornerstone investorKathy Sharrard2022-08-15T14:53:37+09:30August 15th, 2022|
Kathy Sharrard2022-07-06T13:04:19+09:30How small proteins called chemokines could be the answer to getting cancer-busting CAR-T cells directly into solid tumoursKathy Sharrard2022-07-06T13:04:19+09:30July 6th, 2022|